NHP.V) (the “Company” or “Mondias“), which specializes in evidence-based botanical products for the healthcare and bio-agriculture markets, today announced that it has launched its BazzzicsTM Sleep Aid product line. BazzzicsTM is a natural health product line with ingredients that have demonstrated efficacy for sleep and anxiety disorders. Each of the new products addresses a key element of sleep hygiene, namely, sleep anxiety, sleep onset or sleep maintenance. The products are made with a proprietary mix of plant-based extracts, including patented active ingredient CALPXT96.
“The entire Mondias team has worked diligently to create our new lineup of sleep aids. Working with our marketing partners, we’ve entered the digital retail space to accelerate product sales. The ability to move from concept, to manufacturing, to product launch; demonstrates our commitment to expanding our natural products portfolio. The Company is committed to exceptional growth while ensuring safe, effective and environmentally conscious products are available for our customers,” says Dr. Patrick Frankham , CEO of Mondias.
industry reports, the global sleep aids market was valued at $49.5 billion in 2016 and is estimated to reach $79.9 billion by 2022, with a CAGR of 7.0% from 2017 to 2023. Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders stem from substance misuse, a stressful work environment or an inconsistent sleep pattern. Sleep aids help improve sleep quality by reducing the time required to fall asleep and increasing the duration of quality sleep.
www.bazzzics.com.
www.mondias.ca
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Mondias Natural Products Inc.
http://www.newswire.ca/en/releases/archive/December2019/19/c6716.html